Redwood City, CA – According to filings with the U.S. Securities and Exchange Commission, Biotricity is raising $10,000,000.00 in new funding. Sources indicate as part of senior management Chief Financial Officer, John Ayanoglou played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Biotricity

Biotricity is a medical technology company committed to improving healthcare by developing solutions that aid chronic disease prevention and management. Biotricity’s premier product is Bioflux, an ECG monitoring system that will be prescribed by physicians to diagnose and remotely monitor cardiac patients. Biotricity is expanding medical-grade monitoring into the consumer market via its Biolife solution, which empowers users to self-manage chronic conditions. Biolife helps users make lifestyle changes by combining medically relevant ECG data with social media interactivity and a lifestyle log.

To learn more about Biotricity, visit http://www.biotricity.com/

Contact:
John Ayanoglou, Chief Financial Officer
416-214-3678
https://www.linkedin.com/in/johnayanoglou/

SOURCE: http://www.intelligence360.io
Copyright (c) 2019 SI360 Inc. All rights reserved